Literature DB >> 18945873

Anaerobic bacterial infection in patients with cystic fibrosis.

Andrew Tai, Sarath Ranganath.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18945873     DOI: 10.1164/ajrccm.178.9.994

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

Review 1.  Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy.

Authors:  Edith T Zemanick; J Kirk Harris; Steven Conway; Michael W Konstan; Bruce Marshall; Alexandra L Quittner; George Retsch-Bogart; Lisa Saiman; Frank J Accurso
Journal:  J Cyst Fibros       Date:  2009-10-14       Impact factor: 5.482

Review 2.  Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.

Authors:  James F Chmiel; Timothy R Aksamit; Sanjay H Chotirmall; Elliott C Dasenbrook; J Stuart Elborn; John J LiPuma; Sarath C Ranganathan; Valerie J Waters; Felix A Ratjen
Journal:  Ann Am Thorac Soc       Date:  2014-10

3.  Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations.

Authors:  Mehdi Layeghifard; Hannah Li; Pauline W Wang; Sylva L Donaldson; Bryan Coburn; Shawn T Clark; Julio Diaz Caballero; Yu Zhang; D Elizabeth Tullis; Yvonne C W Yau; Valerie Waters; David M Hwang; David S Guttman
Journal:  NPJ Biofilms Microbiomes       Date:  2019-01-21       Impact factor: 7.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.